As Oregon continues to expand its regulated psilocybin services program—and Colorado’s own program begins offering facilitated sessions—clinicians across the country are being asked to engage with this rapidly evolving field. With licensed service centers now operating in both states, legal psilocybin therapy is no longer theoretical.
If you're a clinician or therapist, you may soon encounter patients who are considering, or have already undergone, psilocybin experiences through these state-regulated models. Would you know how to assess whether it's safe for them? Would you understand what the therapeutic process actually looks like?
While psilocybin remains federally illegal, Oregon and Colorado are actively shaping the future of psychedelic-assisted therapy, and clinicians will be on the front lines of supporting patients navigating this new terrain.
In this webinar, experts will break down:
- How Oregon and Colorado's psilocybin programs are functioning in real time
- What kinds of patients are seeking psilocybin services, and why
- What clinicians need to consider when it comes to medical risk
- Can clinicians legally refer to these programs
- What the implications are for physicians nationwide
Whether you're practicing in a state with legal psilocybin services or preparing for future policy changes, this conversation will help you stay informed and ready to support your patients safely and effectively.
As always, there will be ample time for audience Q&A, so you’ll get to interact with the panelists directly!
So please join us for this live panel discussion on Tuesday, July 22nd at 5 pm Pacific, 8 pm Eastern. This is exclusively for members of the Psychedelic Medicine Association, so if you have not yet registered, please do so here. And for members, please register for the panel here. A link to the recording will be available afterward if you cannot make it to the live event.

